Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical TrialHong Yang, Yuping Chen, Chengchu Zhu et al.|Journal of Clinical Oncology|2018Cited by 976
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort studyXiaobin Zhang, Ben M. Eyck, Yang Yang et al.|BMC Cancer|2020Cited by 40